Terms: = Lung cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
14 results:
1. Pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through axin2.
Cao W; Dai S; Ruan W; Long T; Zeng Z; Lei S
J Cell Mol Med; 2023 Sep; 27(17):2533-2546. PubMed ID: 37488774
[TBL] [Abstract] [Full Text] [Related]
2. Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management.
Wen R; Chen Y; Long J; Huang X; Guo Y; Lin B; Yu Z
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8307-8316. PubMed ID: 37074454
[TBL] [Abstract] [Full Text] [Related]
3. Alteration of Cellular Energy Metabolism through LPAR2-axin2 Axis in Gastric cancer.
Ara H; Subedi U; Sharma P; Bhattarai S; Sharma S; Manikandan S; Yu X; Bhuiyan MS; Sun H; Miriyala S; Panchatcharam M
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551233
[TBL] [Abstract] [Full Text] [Related]
4. Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven lung Tumorigenesis.
Vaishnavi A; Juan J; Jacob M; Stehn C; Gardner EE; Scherzer MT; Schuman S; Van Veen JE; Murphy B; Hackett CS; Dupuy AJ; Chmura SA; van der Weyden L; Newberg JY; Liu A; Mann K; Rust AG; Weiss WA; Kinsey CG; Adams DJ; Grossmann A; Mann MB; McMahon M
Cancer Res; 2022 Nov; 82(22):4261-4273. PubMed ID: 36112789
[TBL] [Abstract] [Full Text] [Related]
5. Repurposing clofazimine for malignant pleural mesothelioma treatment - In-vitro assessment of efficacy and mechanism of action.
Parvathaneni V; Chilamakuri R; Kulkarni NS; Wang X; Agarwal S; Gupta V
Life Sci; 2022 Oct; 306():120843. PubMed ID: 35908620
[TBL] [Abstract] [Full Text] [Related]
6. Novel mutation signatures in the prognosis of EGFR-TKIs targeted therapy for non-small cell lung cancer patients based on the 1000-gene panel sequencing.
Zhang H; Jiang D; Jin H; Cui YZ; Wei SJ; Li Y; Dong Q; Zuo J; Tian CJ; Yan F; Wang XW
Neoplasma; 2022 Mar; 69(2):352-360. PubMed ID: 35081725
[TBL] [Abstract] [Full Text] [Related]
7. Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway.
Zhang M; Du H; Wang L; Yue Y; Zhang P; Huang Z; Lv W; Ma J; Shao Q; Ma M; Liang X; Yang T; Wang W; Zeng J; Chen G; Wang X; Fan J
Chem Biol Interact; 2020 Apr; 320():109022. PubMed ID: 32112862
[TBL] [Abstract] [Full Text] [Related]
8. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling.
Ji P; Zhou Y; Yang Y; Wu J; Zhou H; Quan W; Sun J; Yao Y; Shang A; Gu C; Zeng B; Firrman J; Xiao W; Bals R; Sun Z; Li D
Theranostics; 2019; 9(8):2209-2223. PubMed ID: 31149039
[No Abstract] [Full Text] [Related]
9. TGFβ-Induced lung cancer Cell Migration Is NR4A1-Dependent.
Hedrick E; Mohankumar K; Safe S
Mol Cancer Res; 2018 Dec; 16(12):1991-2002. PubMed ID: 30072581
[TBL] [Abstract] [Full Text] [Related]
10. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
11. A Shared Pattern of β-Catenin Activation in Bronchopulmonary Dysplasia and Idiopathic Pulmonary Fibrosis.
Sucre JMS; Deutsch GH; Jetter CS; Ambalavanan N; Benjamin JT; Gleaves LA; Millis BA; Young LR; Blackwell TS; Kropski JA; Guttentag SH
Am J Pathol; 2018 Apr; 188(4):853-862. PubMed ID: 29355514
[TBL] [Abstract] [Full Text] [Related]
12. Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
Tong Y; Liu Y; Zheng H; Zheng L; Liu W; Wu J; Ou R; Zhang G; Li F; Hu M; Liu Z; Lu L
Oncotarget; 2016 May; 7(21):31413-28. PubMed ID: 27119499
[TBL] [Abstract] [Full Text] [Related]
13. Wnt-C59 arrests stemness and suppresses growth of nasopharyngeal carcinoma in mice by inhibiting the Wnt pathway in the tumor microenvironment.
Cheng Y; Phoon YP; Jin X; Chong SY; Ip JC; Wong BW; Lung ML
Oncotarget; 2015 Jun; 6(16):14428-39. PubMed ID: 25980501
[TBL] [Abstract] [Full Text] [Related]
14. Pulmonary resection for malignancy in the elderly: is age still a risk factor?
Pagni S; McKelvey A; Riordan C; Federico JA; Ponn RB
Eur J Cardiothorac Surg; 1998 Jul; 14(1):40-4; discussion 44-5. PubMed ID: 9726613
[TBL] [Abstract] [Full Text] [Related]
